Notícias e Atividades da Zuellig Pharma

Zuellig Pharma pertence à Zuellig Group. Zuellig Group tem presença direta em 3 países.

Zuellig Group possui 4 subsidiárias incluindo Green Cross Health, Pharma Industries e Zuellig Pharma.

Eles estão dentro:

• Saúde40%
• Farmacêutica40%
• Outro20%

Veja o organograma con seus 18 executivos principais

Biografias mais buscadas da Zuellig Pharma

• John Graham, Chief Executive Officer
• Patrick Davies, Chairman of the Board
• Giuseppe Leo, Senior Vice President, Clinical Reach

Criar um alerta
para seguir os movimentos de executivos da Zuellig Pharma.

Zuellig Group possui 2.048 concorrentes concorrentes UnitedHealth Group (Estados Unidos), Siemens Healthineers (Alemanha) e Optum (Estados Unidos).

Popular M&A news in Saúde

• Accolade and Accolade have announced they will merge  (publicado em 9 de abril de 2025)..
• Solace Health acaba de anunciar uma arrecadação de fundos de 60 milhões de dólares. (publicado em 4 de abril de 2025).
• Navina acaba de anunciar uma arrecadação de fundos de 55 milhões de dólares. (publicado em 30 de março de 2025).

Outros contatos sugeridos na indústria do Saúde

• Paulo Junqueira Moll - Chief Executive Officer da Rede D'Or Sao Luiz
• Ari Bousbib - Chairman and Chief Executive Officer da IQVIA
• Bryan Roberts - Director da Included Health

Saiba mais sobre a indústria do Saúde

Últimos comunicados de imprensa de Zuellig Pharma

• Tackling Affordability and Access to Healthcare in an Ever-Evolving World
• Zuellig Pharma acquires Propan from ADP Pharma Corporation in the Philippines
• Prioritising Patient Safety with Effective Digital Healthcare Management
• A Sustainable Approach to Healthcare Access Through Innovative Solutions
• Zuellig Pharma awarded EcoVadis Platinum Medal for fourth consecutive year, among top 60 companies worldwide
• Managing Asia’s healthcare waste and emissions remains challenging amid increasing climate risks
• Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets
• Interpharma Investments Limited appoints Shai Ganu as Member of Board of Directors
• Interpharma Investments Limited appoints multidisciplinary healthcare leader Christiane Hamacher as new board director
• Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia
• View more press releases Close

Redes sociais sobre Zuellig Pharma

• Zuellig Pharma na Wikipedia, Google News e Yahoo Finance
• Zuellig Pharma na LinkedIn, Twitter e YouTube